Healthcare of Ontario Pension Plan Trust Fund Buys 1,178,766 Shares of Kenvue Inc. $KVUE

Healthcare of Ontario Pension Plan Trust Fund increased its stake in Kenvue Inc. (NYSE:KVUE) by 1,551.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,254,735 shares of the company’s stock after buying an additional 1,178,766 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Kenvue were worth $21,644,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Elyxium Wealth LLC bought a new position in Kenvue in the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. increased its stake in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after purchasing an additional 618 shares in the last quarter. SBI Securities Co. Ltd. increased its stake in shares of Kenvue by 82.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after purchasing an additional 1,027 shares in the last quarter. Leonteq Securities AG bought a new position in shares of Kenvue during the fourth quarter valued at approximately $45,000. Finally, Quarry LP bought a new position in shares of Kenvue during the fourth quarter valued at approximately $76,000. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on KVUE shares. UBS Group decreased their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Weiss Ratings downgraded shares of Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Finally, Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $19.33.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.59% of the company’s stock.

Kenvue Price Performance

Shares of KVUE opened at $18.25 on Tuesday. The company has a market capitalization of $35.03 billion, a P/E ratio of 21.47, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $17.45 and a 200 day moving average of $17.55. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same quarter last year, the company posted $0.24 earnings per share. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities research analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.5%. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.